Sprout2.

PositionTRIANGLE BRIEFS: RALEIGH

Sprout2 raised $4.5 million from 203 investors. The company is the successor to Sprout Pharmaceuticals, which was acquired in 2015 by Valeant Pharmaceuticals. The Canada-based d rug maker divested the company in 2017. Sprout2...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT